Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: A two-year follow-up study

Vaccine

Volumn 32, Issue 1, 2013, Pages 119-123

  Erra, Elina O ^a,b   Askling, Helena Hervius ^c   Yoksan, Sutee ^d   Rombo, Lars ^c,e   Riutta, Jukka ^f   Vene, Sirkka ^g   Lindquist, Lars ^c   Vapalahti, Olli ^a,b,h   Kantele, Anu ^a,b,f,h  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c KAROLINSKA INSTITUTE   (Sweden)

^d MAHIDOL UNIVERSITY   (Thailand)

^e Sormland County Council   (Sweden)

^f Aava Medical Centre   (Finland)

^g SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^h UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Booster; Cross protection; Duration of protection; Ixiaro; Japanese encephalitis; Vaccine

Indexed keywords

JAPANESE ENCEPHALITIS VACCINE; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSS PROTECTION; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; JAPANESE ENCEPHALITIS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; VACCINATION; VIRUS CULTURE; VIRUS NEUTRALIZATION; VIRUS PLAQUE; VIRUS STRAIN; VIRUS TITRATION; YOUNG ADULT;

BOOSTER; CROSS-PROTECTION; DURATION OF PROTECTION; GENOTYPE I; GENOTYPE II; GENOTYPE III; GENOTYPE IV; GENOTYPE V; GEOMETRIC MEAN TITER; GI; GII; GIII; GIV; GMT; GV; IXIARO; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; JE; JEV; PLAQUE-REDUCTION NEUTRALIZATION TEST; PRNT; VACCINE;

ADULT; AGED; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CROSS PROTECTION; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNIZATION, SECONDARY; JAPANESE ENCEPHALITIS VACCINES; MALE; MIDDLE AGED; TRAVEL MEDICINE; VACCINATION; YOUNG ADULT;

EID: 84891935899     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.10.055     Document Type: Article

References (23)

1. Solomon T. Control of Japanese encephalitis - within our grasp. N Engl J Med 2006, 355:869-871.
2. World Health Organization Japanese encephalitis vaccines. Wkly Epidemiol Rec 2006, 81:331-340.
3. Shlim D.R., Solomon T. Japanese encephalitis vaccine for travelers: exploring the limits of risk. Clin Infect Dis 2002, 35:183-188.
4. Wilder-Smith A., Halstead S.B. Japanese encephalitis: update on vaccines and vaccine recommendations. Curr Opin Infect Dis 2010, 23:426-431.
5. Erra E.O., Askling H.H., Rombo L., Riutta J., Vene S., Yoksan S., et al. Single dose of Vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines. Clin Infect Dis 2012, 55:825-834.
6. Woolpert T., Staples J.E., Faix D.J., Nett R.J., Kosoy O.I., Biggerstaff B.J., et al. Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine. Vaccine 2012, 30:3090-3096.
7. Solomon T., Ni H., Beasley D.W.C., Ekkelenkamp M., Cardosa M.J., Barrett A.D.T. Origin and evolution of Japanese encephalitis virus in southeast Asia. J Virol 2003, 77:3091-3098.
8. Mackenzie J.S., Gubler D.J., Petersen L.R. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 2004, 10:S98-S109.
9. Ma S.P., Yoshida Y., Makino Y., Tadano M., Ono T., Ogawa M. Short report: a major genotype of Japanese encephalitis virus currently circulating in Japan. Am J Trop Med Hyg 2003, 69:151-154.
10. Nitatpattana N., Dubot-Pérès A., Gouilh M.A., Souris M., Barbazan P., Yoksan S., et al. Change in Japanese encephalitis virus distribution, Thailand. Emerg Infect Dis 2008, 14:1762-1765.
11. Chen Y.Y., Fan Y.C., Tu W.C., Chang R.Y., Shih C.C., Lu I.H., et al. Japanese encephalitis virus genotype replacement, Taiwan, 2009-2010. Emerg Infect Dis 2011, 17:2354-2356.
12. Pan X.L., Liu H., Wang H.Y., Fu S.H., Liu H.Z., Zhang H.L., et al. Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia. J Virol 2011, 85:9847-9853.
13. Chen W., Rico-Hesse R., Tesh R.B. A new genotype of Japanese encephalitis virus from Indonesia. Am J Trop Med Hyg 1992, 47:61-69.
14. Williams D.T., Wang L.F., Daniels P.W., Mackenzie J.S. Molecular characterization of the first Australian isolate of Japanese encephalitis virus, the FU strain. J Gen Virol 2000, 81:2471-2480.
15. Takhampunya R., Kim H.C., Tippayachai B., Kengluecha A., Klein T.A., Lee W.J., et al. Emergence of Japanese encephalitis virus genotype V in the Republic of Korea. Virol J 2011, 8:449.
16. Erra E.O., Askling H.H., Yoksan S., Rombo L., Riutta J., Vene S., et al. Crossprotective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes. Clin Infect Dis 2013, 56:267-270.
17. Hombach J., Solomon T., Kurane I., Jacobson J., Wood D. Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004. Vaccine 2005, 23:5205-5211.
18. Russell P.K., Nisalak A., Sukhavachana P., Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol 1967, 99:285-290.
19. Schuller E., Jilma B., Voicu V., Golor G., Kollaritsch H., Kaltenböck A., et al. Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 six and 12 month results of a multicenter follow-up phase 3 study. Vaccine 2008, 26:4382-4386.
20. Dubischar-Kastner K., Eder S., Buerger V., Gartner-Woelfl G., Kaltenboeck A., Schuller E., et al. Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO, IC51. Vaccine 2010, 28:5197-5202.
21. Eder S., Dubischar-Kastner K., Firbas C., Jelinek T., Jilma B., Kaltenboeck A., et al. Long term immunity following a booster dose of the inactivated Japanese encephalitis vaccine IXIARO, IC51. Vaccine 2011, 29:2607-2612.
22. Ixiaro: EPAR - Product Information. Updated 19/04/2013. [accessed 01.07.13]. http://www.ema.europa.eu/ema/index.jsp%3Fcurl=pages/medicines/human/medicines/000963/human_med_000862.jsp%26mid=WC0b01ac058001d124.
23. The National Institute for Health and Welfare. Hanna Nohynek and Ulpu Elonsalo: Japanese encephalitis. Matkailijan terveysopas 2013 [in Finnish]. Updated 25/03/2013. [Accessed 27.06.13]. http://www.terveyskirjasto.fi/terveyskirjasto/ktl.mat%3Fp_artikkeli=mat00039.